Johnson & Johnson, headquartered in New Jersey, is asking the Food and Drug Administration for emergency use authorization of the world’s first single-dose COVID-19 vaccination. Once approved, Johnson & Johnson could start sending out supplies of the vaccine within four weeks, and without the need for ultra-cold storage.
The company is promising 100 million doses for the U.S. by the end of June, as infectious disease experts warn of dangerous new virus variants that could take hold in the country before those doses are shipped.
Rutgers University Professor of Medicine Dr. Martin Blaser tells Anchor Briana Vannozzi that the timing of this vaccine is critical.